Amlodipine Besylate And Benazepril Hydrochloride Capsule
Product Images NDC 51655-201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Benazepril Hydrochloride (NDC 51655-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure01 (Structure01)

Chemical structure of Amlodipine Besylate and Benazepril Hydrochloride, showing the molecular arrangement including carbon, hydrogen, nitrogen, and oxygen atoms along with molecular groups such as carboxyl and benzyl units.*

FDA Label Image

Structure02 (Structure02)

Chemical structure diagram of Amlodipine Besylate and Benazepril Hydrochloride, showing the molecular arrangement of atoms and functional groups for these active ingredients in the medication.*

FDA Label Image

Label (51655 201 52 Rev A 04 23 Nhc)

Label for Amlodipine Besylate and Benazepril Hydrochloride Capsules, USP 5 mg/20 mg strength. The package contains 30 capsules. It is a prescription drug labeled by Northwind Health Company, LLC. Storage instructions specify 20°-25°C (68°-77°F). Additional labeling includes dosage reference, barcode, and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.